B/BE/23/BVW3 - Informatie fiche bestemd voor het publiek (voorbereid door de kennisgever)

File: 
Icône PDF bbe23bvw3_pub_nl.pdf
Trial reference: 
A Phase I, randomized, double-blind, multi-centre, placebo-controlled, dose-escalation study to evaluate the safety, reactogenicity and immunogenicity of AstriVax’ investigational vaccine for the prevention of yellow fever (AVX70120), and of AstriVax’ inv
Doc type: 
Information for the public